دورية أكاديمية
[Mesenchymal and Non-meningothelial Tumors Involving the Central Nervous System].
| العنوان: | [Mesenchymal and Non-meningothelial Tumors Involving the Central Nervous System]. |
|---|---|
| المؤلفون: | Oya S; Department of Neurosurgery, Saitama Medical Center, Saitama Medical University., Murakami C |
| المصدر: | No shinkei geka. Neurological surgery [No Shinkei Geka] 2023 Sep; Vol. 51 (5), pp. 837-844. |
| نوع المنشور: | English Abstract; Journal Article |
| اللغة: | Japanese |
| بيانات الدورية: | Publisher: Igaku Shoin Country of Publication: Japan NLM ID: 0377015 Publication Model: Print Cited Medium: Print ISSN: 0301-2603 (Print) Linking ISSN: 03012603 NLM ISO Abbreviation: No Shinkei Geka Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Tokyo, Igaku Shoin. |
| مواضيع طبية MeSH: | Severe Fever with Thrombocytopenia Syndrome* , Brain Neoplasms*/genetics , Soft Tissue Neoplasms* , Sarcoma*, Humans ; Central Nervous System ; Ribonuclease III ; DEAD-box RNA Helicases |
| مستخلص: | In the World Health Organization Classification of Brain Tumors Fifth Edition, mesenchymal non-meningothelial tumors involving the central nervous system are divided into three major categories: soft tissue tumors, chondro-osseous tumors, and notochordal tumors. Soft tissue tumors are classified into four groups: fibroblastic and myofibroblastic tumors, vascular tumors, skeletal muscle tumors, and tumors of uncertain differentiation. This article will focus on solitary fibrous tumors(SFTs), which are frequently encountered clinically and continue to undergo classification revisions in the 5 th edition, and outline the three newly added histological diagnoses. Although SFTs and hemangiopericytomas occur throughout the body, including the central nervous system, nomenclatures have been different between the classifications of "Tumours of Soft Tissue and Bone" and "Tumours of the Central Nervous System." The latest nomenclature is "SFT" in accordance with the nomenclature of bone and soft-tissue tumors. In addition, three new diagnoses, which are intracranial mesenchymal tumor FET-CREB fusion-positive, CIC -rearranged sarcoma, and primary intracranial sarcoma DICER1 -mutant, have been defined based on genetic abnormalities in tumors of uncertain differentiation. |
| المشرفين على المادة: | EC 3.1.26.3 (DICER1 protein, human) EC 3.1.26.3 (Ribonuclease III) EC 3.6.4.13 (DEAD-box RNA Helicases) |
| تواريخ الأحداث: | Date Created: 20230924 Date Completed: 20230926 Latest Revision: 20230926 |
| رمز التحديث: | 20240514 |
| DOI: | 10.11477/mf.1436204825 |
| PMID: | 37743335 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0301-2603 |
|---|---|
| DOI: | 10.11477/mf.1436204825 |